DEA medical marijuana registrations were issued for the first time to state-licensed dispensaries, a move that could unlock federal tax deductions long out of reach for the cannabis industry.
The U.S. Drug Enforcement Administration granted registrations Friday to more than 900 dispensaries operating under state medical programs in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia, according to the Justice Department. Officials did not release the names of the approved businesses.
Attorney General Todd Blanche said regulated distribution of cannabis for medical use through these shops would broaden access to chronic pain treatment and enhance public safety.
The action follows an April order shifting state-licensed medical marijuana from Schedule I to Schedule III. Schedule I is reserved for substances with no accepted medical use and high abuse potential, while Schedule III carries less stringent controls.
The rescheduling effectively recognized medical cannabis programs in 40 states and created an expedited path for state-licensed producers, manufacturers and distributors to register with the DEA.
Applicants must clear a pre-registration review and meet requirements for security, recordkeeping, inventory management and other safeguards for controlled substances.
Registration is expected to bring significant federal tax advantages. Until now, cannabis businesses could not deduct typical expenses such as advertising, rent or sales-related labor on federal returns because marijuana remained a Schedule I substance, a limitation that many operators have described as financially punishing.
Nearly 7,000 additional dispensaries, manufacturers and distributors have also applied for DEA registration, according to a list the agency published Friday.
Steph Sherer, founder of Americans for Safe Access, noted the timing comes days before the 30th anniversary of California’s pioneering medical marijuana law, calling the federal recognition of medical dispensaries a major win for patient access and a milestone after decades of advocacy.
What DEA medical marijuana registrations mean next
Key questions remain about how federal oversight will mesh with state systems. Rules for state-licensed cannabis businesses often differ from those governing most Schedule III handlers, and it is not yet clear what requirements the DEA will set for medical marijuana operations.
For instance, some states have allowed people with certain criminal histories to participate in the legal market to counter past drug-war impacts. It is uncertain whether the DEA will take a similar approach with the entities it registers.
Another area of uncertainty involves states that combine medical and adult-use markets. While the administration has sought broader marijuana rescheduling, it is not yet clear how the DEA will treat businesses serving both recreational and medical customers.
To date, two dozen states and Washington, D.C., allow adult recreational use, 40 operate medical systems, and eight more permit low-THC cannabis or CBD oil for medical treatment.
Only Idaho and Kansas maintain complete bans.
Industry observers say the new framework is a constructive development, but they are watching for detailed compliance expectations for companies that now fall under Schedule III rules.
This shift will be closely followed in Hawaiʻi, where medical cannabis is legal statewide and businesses have long navigated the tax and banking challenges tied to federal status.
Clearer federal guidance and access to deductions could reshape operations and investment for local licensees.
One Response